1. Daya S, Gunby J. Luteal phase support in assisted reproductive cycles. (Cochrane review). The Cochrane library. UK: John Wiley and Sons Ltd., 2004; 3.
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.
________________________________________________
1. Daya S, Gunby J. Luteal phase support in assisted reproductive cycles. (Cochrane review). The Cochrane library. UK: John Wiley and Sons Ltd., 2004; 3.
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.